NT5E and neoplasm: Accordingly, inhibitors of ATP hydrolyzing enzymes CD39, CD73, and adenosine A2A receptor antagonists, which are considered the next generation of immune checkpoint inhibitors, significantly reduce tumor growth by improving T cell-mediated responses (Vijayan et al., 2017).